US FDA approves expanded use of Merck’s Gardasil 9 vaccine to include individuals 27 through 45 years old

The US Food and Drug Administration (FDA) approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.

Reasons why the screening programs may not be uniform

We may tend to think of our health-care system as a national program. In reality, the states and territories are responsible for delivering health-care services. That means local authorities are in charge of setting up health programs and sometimes opinions vary about what’s the best approach. As a result, cancer screening can differ from one…